The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2009 AND VI 14 AND IP 4
Results: 16
1
2
Step change in safe harbors: public-private partnerships.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Commentary: Troublesome Words, Linguistic Precision, and Medical Oncology.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
4
Current Treatment Approaches for Infants with Malignant Central Nervous System Tumors.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 433, doi. 10.1634/theoncologist.2008-0193
- By:
- Publication type:
- Article
5
Salvage Therapy in Hodgkin's Lymphoma.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 425, doi. 10.1634/theoncologist.2009-0002
- By:
- Publication type:
- Article
6
The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 412, doi. 10.1634/theoncologist.2008-0190
- By:
- Publication type:
- Article
7
Reflections.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 411, doi. 10.1634/theoncologist.2009-4000
- Publication type:
- Article
8
Combined Inhibition of the VEGFR and EGFR Signaling Pathways in the Treatment of NSCLC.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 399, doi. 10.1634/theoncologist.2008-0276
- By:
- Publication type:
- Article
9
Immunotherapeutics in Development for Prostate Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 391, doi. 10.1634/theoncologist.2008-0240
- By:
- Publication type:
- Article
10
Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 378, doi. 10.1634/theoncologist.2008-0261
- By:
- Publication type:
- Article
11
Measuring Response with FDG-PET: Methodological Aspects.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 369, doi. 10.1634/theoncologist.2008-0119
- By:
- Publication type:
- Article
12
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti--HER-2 Therapy and Personalized Medicine.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 320, doi. 10.1634/theoncologist.2008-0230
- By:
- Publication type:
- Article
13
Vision and Will: The Future of the FDA.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
14
Four Important Steps Toward 21st Century Care for Patients with Cancer.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
15
Facilitating Patient-Centered Cancer Research and a New Era of Drug Discovery.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
16
Step Change in Safe Harbors: Public--Private Partnerships.
- Published in:
- 2009
- By:
- Publication type:
- Editorial